Platelet-activating factor causes ventilation-perfusion mismatch in humans
- PMID: 8282786
- PMCID: PMC293752
- DOI: 10.1172/JCI116944
Platelet-activating factor causes ventilation-perfusion mismatch in humans
Abstract
We hypothesized that platelet-activating factor (PAF), a potent inflammatory mediator, could induce gas exchange abnormalities in normal humans. To this end, the effect of aerosolized PAF (2 mg/ml solution; 24 micrograms) on ventilation-perfusion (VA/Q) relationships, hemodynamics, and resistance of the respiratory system was studied in 14 healthy, nonatopic, and nonsmoking individuals (23 +/- 1 [SEM]yr) before and at 2, 4, 6, 8, 15, and 45 min after inhalation, and compared to that of inhaled lyso-PAF in 10 other healthy individuals (24 +/- 2 yr). PAF induced, compared to lyso-PAF, immediate leukopenia (P < 0.001) followed by a rebound leukocytosis (P < 0.002), increased minute ventilation (P < 0.05) and resistance of the respiratory system (P < 0.01), and decreased systemic arterial pressure (P < 0.05). Similarly, compared to lyso-PAF, PaO2 showed a trend to fall (by 12.2 +/- 4.3 mmHg, mean +/- SEM maximum change from baseline), and arterial-alveolar O2 gradient increased (by 16.7 +/- 4.3 mmHg) (P < 0.02) after PAF, because of VA/Q mismatch: the dispersion of pulmonary blood flow and that of ventilation increased by 0.45 +/- 0.1 (P < 0.01) and 0.29 +/- 0.1 (P < 0.04), respectively. We conclude that in normal subjects, inhaled PAF results in considerable immediate VA/Q inequality and gas exchange impairment. These results reinforce the notion that PAF may play a major role as a mediator of inflammation in the human lung.
Similar articles
-
Salbutamol inhibits pulmonary effects of platelet activating factor in man.Am J Respir Crit Care Med. 1995 Jun;151(6):1740-4. doi: 10.1164/ajrccm.151.6.7767515. Am J Respir Crit Care Med. 1995. PMID: 7767515 Clinical Trial.
-
Inhaled platelet-activating factor worsens gas exchange in mild asthma.Am J Respir Crit Care Med. 1994 Aug;150(2):369-73. doi: 10.1164/ajrccm.150.2.8049817. Am J Respir Crit Care Med. 1994. PMID: 8049817
-
The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1559-64. doi: 10.1164/ajrccm.157.5.9711088. Am J Respir Crit Care Med. 1998. PMID: 9603138 Clinical Trial.
-
[Gas exchange in acute respiratory distress syndrome].Medicina (B Aires). 2003;63(2):157-64. Medicina (B Aires). 2003. PMID: 12793087 Review. Spanish.
-
Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities.Eur Respir J. 1997 Jun;10(6):1359-71. doi: 10.1183/09031936.97.10061359. Eur Respir J. 1997. PMID: 9192945 Review.
Cited by
-
Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.Inflammation. 2008 Apr;31(2):112-20. doi: 10.1007/s10753-007-9056-9. Epub 2008 Jan 12. Inflammation. 2008. PMID: 18193345 Review.
-
Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.J Exp Med. 1996 Jul 1;184(1):191-201. doi: 10.1084/jem.184.1.191. J Exp Med. 1996. PMID: 8691134 Free PMC article.
-
Pathophysiology of food-induced anaphylaxis.Curr Allergy Asthma Rep. 2008 May;8(3):201-8. doi: 10.1007/s11882-008-0034-6. Curr Allergy Asthma Rep. 2008. PMID: 18589838 Review.
-
Contributions of multiple inert gas elimination technique to pulmonary medicine.3. Bronchial asthma.Thorax. 1994 Oct;49(10):1027-33. doi: 10.1136/thx.49.10.1027. Thorax. 1994. PMID: 7974299 Free PMC article. Review. No abstract available.